These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2437886)

  • 1. Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?
    Schleiss MR
    Future Virol; 2013 Dec; 8(12):1161-1182. PubMed ID: 24523827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.
    Martelius T; Salmi M; Wu H; Bruggeman C; Höckerstedt K; Jalkanen S; Lautenschlager I
    Am J Pathol; 2000 Oct; 157(4):1229-37. PubMed ID: 11021827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain.
    Beisser PS; Grauls G; Bruggeman CA; Vink C
    J Virol; 1999 Sep; 73(9):7218-30. PubMed ID: 10438809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection.
    Beisser PS; Vink C; Van Dam JG; Grauls G; Vanherle SJ; Bruggeman CA
    J Virol; 1998 Mar; 72(3):2352-63. PubMed ID: 9499096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    J Clin Invest; 1993 Aug; 92(2):549-58. PubMed ID: 8394384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
    Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients.
    Hendrix MG; Dormans PH; Kitslaar P; Bosman F; Bruggeman CA
    Am J Pathol; 1989 May; 134(5):1151-7. PubMed ID: 2541613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host.
    Stals FS; Bosman F; van Boven CP; Bruggeman CA
    Arch Virol; 1990; 114(1-2):91-107. PubMed ID: 2171466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers.
    Span AH; Mullers W; Miltenburg AM; Bruggeman CA
    Immunology; 1991 Mar; 72(3):355-60. PubMed ID: 1709139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.
    Stals FS; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational specificity of monoclonal antibodies used in the diagnosis of tomato mosaic virus.
    Dekker EL; Dore I; Porta C; van Regenmortel MH
    Arch Virol; 1987; 94(3-4):191-203. PubMed ID: 2437887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production of monoclonal antibodies against respiratory syncytial virus and its clinical applications.
    Wu B
    Clin Lab Med; 1985 Sep; 5(3):589-613. PubMed ID: 3899483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens.
    Bruning JH; Debie WH; Dormans PH; Meijer H; Bruggeman CA
    Arch Virol; 1987; 94(1-2):55-70. PubMed ID: 2437886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus.
    Kim KS; Sapienza VJ; Chen CM; Wisniewski K
    J Clin Microbiol; 1983 Aug; 18(2):331-43. PubMed ID: 6194174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies neutralizing human cytomegalovirus.
    Masuho Y; Matsumoto Y; Sugano T; Fujinaga S; Minamishima Y
    J Gen Virol; 1987 May; 68 ( Pt 5)():1457-61. PubMed ID: 2437245
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.